Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

What happened

Bluejay Diagnostics said its board approved a 1-for-4 reverse stock split. Every four issued shares will combine into one, cutting outstanding shares from about 4,468,051 to about 1,117,013. It takes effect November 3, 2026, and BJDX trades post-split the same day.

Confirmed

Global impact / market context

A reverse split raises the share price while leaving each holder's ownership stake and the company's total value unchanged, because fewer shares exist. Investors often watch splits when a company seeks to keep its Nasdaq listing, since exchanges can require a minimum share price.

Analyst inference

The move shrinks the share count to roughly one quarter of the prior level, so per-share figures like earnings and losses will look about four times larger without any operational improvement. Trading also begins under a new CUSIP number, which means the security identifier used to track the stock changes.

Analyst inference

What to watch

1. Watch November 3, 2026, when trading opens on a post-split basis under the existing BJDX symbol with the new CUSIP number, 095633707. Confirmed
2. Track how holders of fewer than four shares are handled, since no fractional shares will be issued and the article's text is cut off before explaining that treatment. Confirmed
3. Watch whether the higher post-split share price helps the stock meet Nasdaq's minimum price listing requirement, since the announcement does not state that reason. Analyst inference

Evidence

• accessnewswire.com